BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 36750420)

  • 1. The adhesion G protein-coupled receptor GPR56/ADGRG1 in cytotoxic lymphocytes.
    Hsiao CC; Vos E; van Gisbergen KPJM; Hamann J
    Basic Clin Pharmacol Toxicol; 2023 Oct; 133(4):286-294. PubMed ID: 36750420
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Adhesion G Protein-Coupled Receptor GPR56/ADGRG1 Is an Inhibitory Receptor on Human NK Cells.
    Chang GW; Hsiao CC; Peng YM; Vieira Braga FA; Kragten NA; Remmerswaal EB; van de Garde MD; Straussberg R; König GM; Kostenis E; Knäuper V; Meyaard L; van Lier RA; van Gisbergen KP; Lin HH; Hamann J
    Cell Rep; 2016 May; 15(8):1757-70. PubMed ID: 27184850
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Inhibitory Receptor GPR56 (
    Hsiao CC; Kragten NAM; Piao X; Hamann J; van Gisbergen KPJM
    Cells; 2021 Oct; 10(10):. PubMed ID: 34685654
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Crucial contribution of GPR56/ADGRG1, expressed by breast cancer cells, to bone metastasis formation.
    Sasaki SI; Zhang D; Iwabuchi S; Tanabe Y; Hashimoto S; Yamauchi A; Hayashi K; Tsuchiya H; Hayakawa Y; Baba T; Mukaida N
    Cancer Sci; 2021 Dec; 112(12):4883-4893. PubMed ID: 34632664
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Novel Immune Checkpoint GPR56 Is Expressed on Tumor-Infiltrating Lymphocytes and Selectively Upregulated upon TCR Signaling.
    Bilemjian V; Vlaming MR; Álvarez Freile J; Huls G; De Bruyn M; Bremer E
    Cancers (Basel); 2022 Jun; 14(13):. PubMed ID: 35804934
    [TBL] [Abstract][Full Text] [Related]  

  • 6. GAIN domain-mediated cleavage is required for activation of G protein-coupled receptor 56 (GPR56) by its natural ligands and a small-molecule agonist.
    Zhu B; Luo R; Jin P; Li T; Oak HC; Giera S; Monk KR; Lak P; Shoichet BK; Piao X
    J Biol Chem; 2019 Dec; 294(50):19246-19254. PubMed ID: 31628191
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Specific expression of GPR56 by human cytotoxic lymphocytes.
    Peng YM; van de Garde MD; Cheng KF; Baars PA; Remmerswaal EB; van Lier RA; Mackay CR; Lin HH; Hamann J
    J Leukoc Biol; 2011 Oct; 90(4):735-40. PubMed ID: 21724806
    [TBL] [Abstract][Full Text] [Related]  

  • 8. GPR56/ADGRG1 Activation Promotes Melanoma Cell Migration via NTF Dissociation and CTF-Mediated Gα
    Chiang NY; Peng YM; Juang HH; Chen TC; Pan HL; Chang GW; Lin HH
    J Invest Dermatol; 2017 Mar; 137(3):727-736. PubMed ID: 27818281
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adhesion GPCR GPR56 Expression Profiling in Human Tissues.
    Kaiser F; Morawski M; Krohn K; Rayes N; Hsiao CC; Quaas M; Aust G
    Cells; 2021 Dec; 10(12):. PubMed ID: 34944065
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of GPR56/ADGRG1 in health and disease.
    Singh AK; Lin HH
    Biomed J; 2021 Oct; 44(5):534-547. PubMed ID: 34654683
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti-GPR56 monoclonal antibody potentiates GPR56-mediated Src-Fak signaling to modulate cell adhesion.
    Chatterjee T; Zhang S; Posey TA; Jacob J; Wu L; Yu W; Francisco LE; Liu QJ; Carmon KS
    J Biol Chem; 2021; 296():100261. PubMed ID: 33837725
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of ADGRG1/GPR56 in Tumor Progression.
    Ng KF; Chen TC; Stacey M; Lin HH
    Cells; 2021 Nov; 10(12):. PubMed ID: 34943858
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Splicing variants of the orphan G-protein-coupled receptor GPR56 regulate the activity of transcription factors associated with tumorigenesis.
    Kim JE; Han JM; Park CR; Shin KJ; Ahn C; Seong JY; Hwang JI
    J Cancer Res Clin Oncol; 2010 Jan; 136(1):47-53. PubMed ID: 19572147
    [TBL] [Abstract][Full Text] [Related]  

  • 14. GPR56/ADGRG1 Inhibits Mesenchymal Differentiation and Radioresistance in Glioblastoma.
    Moreno M; Pedrosa L; Paré L; Pineda E; Bejarano L; Martínez J; Balasubramaniyan V; Ezhilarasan R; Kallarackal N; Kim SH; Wang J; Audia A; Conroy S; Marin M; Ribalta T; Pujol T; Herreros A; Tortosa A; Mira H; Alonso MM; Gómez-Manzano C; Graus F; Sulman EP; Piao X; Nakano I; Prat A; Bhat KP; de la Iglesia N
    Cell Rep; 2017 Nov; 21(8):2183-2197. PubMed ID: 29166609
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Downstream signalling of the disease-associated mutations on GPR56/ADGRG1.
    Cevheroğlu O; Demir N; Kesici MS; Özçubukçu S; Son ÇD
    Basic Clin Pharmacol Toxicol; 2023 Oct; 133(4):331-341. PubMed ID: 37056198
    [TBL] [Abstract][Full Text] [Related]  

  • 16. GPR56: An adhesion GPCR involved in brain development, neurological disorders and cancer.
    Ganesh RA; Venkataraman K; Sirdeshmukh R
    Brain Res; 2020 Nov; 1747():147055. PubMed ID: 32798453
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Functions of G protein-coupled receptor 56 in health and disease.
    Su T; Guan Q; Cheng H; Zhu Z; Jiang C; Guo P; Tai Y; Sun H; Wang M; Wei W; Wang Q
    Acta Physiol (Oxf); 2022 Oct; 236(2):e13866. PubMed ID: 35959520
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Activation and Signaling Mechanisms of GPR56/ADGRG1 in Melanoma Cell.
    Huang KY; Lin HH
    Front Oncol; 2018; 8():304. PubMed ID: 30135857
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Orphan G protein-coupled receptor GPR56 regulates neural progenitor cell migration via a G alpha 12/13 and Rho pathway.
    Iguchi T; Sakata K; Yoshizaki K; Tago K; Mizuno N; Itoh H
    J Biol Chem; 2008 May; 283(21):14469-78. PubMed ID: 18378689
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cell type-specific evaluation of ADGRG1/GPR56 function in developmental central nervous system myelination.
    Chiou B; Gao C; Giera S; Folts CJ; Kishore P; Yu D; Oak HC; Jiang R; Piao X
    Glia; 2021 Feb; 69(2):413-423. PubMed ID: 32902916
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.